Related Experiment Video

Updated: Jun 6, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Are cardiovascular benefits in statin lipid effects dependent on baseline lipid levels?

Keith C Ferdinand1

  • 1Division of Cardiology, Emory University, 5355 Hunter Rd., Atlanta, GA 30349, USA. kferdinand@abcardio.org

Current Atherosclerosis Reports
|November 25, 2010
PubMed

Insights

Statins significantly lower low-density lipoprotein cholesterol (LDL-C) and reduce cardiovascular events and total mortality. Despite some criticisms, the JUPITER trial provides strong evidence for rosuvastatin

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Pharmacology

Background:

  • Statins are widely used to reduce coronary heart disease (CHD) morbidity and mortality.
  • The Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial investigated rosuvastatin in patients with elevated C-reactive protein and below-average LDL-C.
  • Recent discussions have raised concerns about the JUPITER trial's design and influence.

Purpose of the Study:

  • To evaluate the efficacy of rosuvastatin in reducing cardiovascular events and mortality in a specific patient population.
  • To address criticisms and contextualize the JUPITER trial findings within broader statin research.

Main Methods:

  • The JUPITER trial enrolled subjects with elevated C-reactive protein but no diagnosed vascular disease and below-average LDL-C.
  • Rosuvastatin (20 mg/d) was administered, and outcomes including LDL-C levels, cardiovascular events, and mortality were assessed.

Main Results:

  • Rosuvastatin resulted in a 50% reduction in LDL-C.
  • A significant reduction in cardiovascular events (hazard ratio 0.56) and total mortality (20%) was observed.
  • Canadian guidelines cite JUPITER as class I evidence, while some meta-analyses show no decrease in all-cause mortality.

Conclusions:

  • The JUPITER trial provides robust evidence for the benefits of rosuvastatin in selected populations.
  • Despite controversies, statin therapy, including rosuvastatin, demonstrates significant cardiovascular risk reduction.
  • Individualized long-term statin therapy decisions are crucial for optimal patient care.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...